Iran medicine prices rise amid sanctions

Iran is facing a severe crisis in the pharmaceutical market due to U.S. sanctions and the imposed blockade, which have led to a significant increase in medication prices and a decline in their availability in pharmacies, especially for vital medicines. Although the country produces over 80% of its domestic needs, the industry heavily relies on imports, which has worsened the crisis amid falling currency values and rising air shipping costs that have become more expensive, coupled with the loss of many international flights due to sanctions. Additionally, airstrikes have damaged over 40 pharmaceutical factories, further deepening patients' suffering and making it even more difficult to obtain essential medicines.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل